Children's Cancer Institute Australia
4 May, 2011

Scientists at Children’s Cancer Institute Australia (CCIA) are developing a new therapy for non-small lung cancer, one of the most lethal types of cancer.

In a twist of fate, scientists looking for a new treatment approach to childhood cancer solid tumours found that this new approach was effective in targeting solid tumours in lung cancer.

The current prognosis for patients with advanced non-small cell lung cancer in Australia is dismal, as tumours often become resistant to conventional drug therapy.

Promising results to be presented at the Australasian Gene Therapy Society meeting in Melbourne suggest that the therapy has the potential to offer new hope to lung cancer patients in Australia and globally.